EUROBIO-SCIENTIFIC (ALERS.PA) Stock Fundamental Analysis
EPA:ALERS - Euronext Paris - Matif - FR0013240934 - Common Stock - Currency: EUR
Overall ALERS gets a fundamental rating of 6 out of 10. We evaluated ALERS against 73 industry peers in the Biotechnology industry. Both the health and profitability get an excellent rating, making ALERS a very profitable company, without any liquidiy or solvency issues. ALERS is not valued too expensively and it also shows a decent growth rate. With these ratings, ALERS could be worth investigating further for quality investing!.
1. Profitability
1.1 Basic Checks
ALERS had positive earnings in the past year.
In the past year ALERS had a positive cash flow from operations.
In the past 5 years ALERS has always been profitable.
Each year in the past 5 years ALERS had a positive operating cash flow.
1.2 Ratios
With a decent Return On Assets value of 1.55%, ALERS is doing good in the industry, outperforming 76.71% of the companies in the same industry.
ALERS's Return On Equity of 2.24% is fine compared to the rest of the industry. ALERS outperforms 78.08% of its industry peers.
The Return On Invested Capital of ALERS (4.25%) is better than 83.56% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ALERS is significantly below the industry average of 11.99%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.55% | ||
| ROE | 2.24% | ||
| ROIC | 4.25% |
ROA(3y)3.54%
ROA(5y)16.42%
ROE(3y)6.48%
ROE(5y)25.15%
ROIC(3y)5.13%
ROIC(5y)17.09%
1.3 Margins
ALERS's Profit Margin of 2.59% is fine compared to the rest of the industry. ALERS outperforms 79.45% of its industry peers.
In the last couple of years the Profit Margin of ALERS has declined.
ALERS's Operating Margin of 8.81% is amongst the best of the industry. ALERS outperforms 83.56% of its industry peers.
In the last couple of years the Operating Margin of ALERS has grown nicely.
ALERS has a Gross Margin of 46.49%. This is comparable to the rest of the industry: ALERS outperforms 57.53% of its industry peers.
ALERS's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.81% | ||
| PM (TTM) | 2.59% | ||
| GM | 46.49% |
OM growth 3Y-38.55%
OM growth 5Y55.68%
PM growth 3Y-57.11%
PM growth 5Y-13.49%
GM growth 3Y-5.65%
GM growth 5Y7%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ALERS is destroying value.
The number of shares outstanding for ALERS remains at a similar level compared to 1 year ago.
ALERS has less shares outstanding than it did 5 years ago.
ALERS has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 3.80 indicates that ALERS is not in any danger for bankruptcy at the moment.
ALERS has a Altman-Z score of 3.80. This is in the better half of the industry: ALERS outperforms 79.45% of its industry peers.
The Debt to FCF ratio of ALERS is 2.53, which is a good value as it means it would take ALERS, 2.53 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of ALERS (2.53) is better than 90.41% of its industry peers.
A Debt/Equity ratio of 0.17 indicates that ALERS is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.17, ALERS is doing good in the industry, outperforming 64.38% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.17 | ||
| Debt/FCF | 2.53 | ||
| Altman-Z | 3.8 |
ROIC/WACC0.61
WACC6.94%
2.3 Liquidity
A Current Ratio of 2.03 indicates that ALERS has no problem at all paying its short term obligations.
With a Current ratio value of 2.03, ALERS perfoms like the industry average, outperforming 50.68% of the companies in the same industry.
A Quick Ratio of 1.42 indicates that ALERS should not have too much problems paying its short term obligations.
The Quick ratio of ALERS (1.42) is worse than 63.01% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.03 | ||
| Quick Ratio | 1.42 |
3. Growth
3.1 Past
The earnings per share for ALERS have decreased by -7.60% in the last year.
The Earnings Per Share has been growing slightly by 6.82% on average over the past years.
ALERS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 18.89%.
Measured over the past years, ALERS shows a very strong growth in Revenue. The Revenue has been growing by 21.21% on average per year.
EPS 1Y (TTM)-7.6%
EPS 3Y-58.79%
EPS 5Y6.82%
EPS Q2Q%-100.04%
Revenue 1Y (TTM)18.89%
Revenue growth 3Y-5.77%
Revenue growth 5Y21.21%
Sales Q2Q%14.74%
3.2 Future
ALERS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 34.84% yearly.
The Revenue is expected to grow by 9.25% on average over the next years. This is quite good.
EPS Next Y31.82%
EPS Next 2Y34.84%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.49%
Revenue Next 2Y9.25%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 62.75 indicates a quite expensive valuation of ALERS.
Based on the Price/Earnings ratio, ALERS is valued cheaply inside the industry as 80.82% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.03. ALERS is valued rather expensively when compared to this.
ALERS is valuated rather expensively with a Price/Forward Earnings ratio of 21.01.
ALERS's Price/Forward Earnings ratio is rather cheap when compared to the industry. ALERS is cheaper than 83.56% of the companies in the same industry.
ALERS's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 36.28.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 62.75 | ||
| Fwd PE | 21.01 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALERS indicates a rather cheap valuation: ALERS is cheaper than 87.67% of the companies listed in the same industry.
ALERS's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ALERS is cheaper than 83.56% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.13 | ||
| EV/EBITDA | 8.75 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of ALERS may justify a higher PE ratio.
ALERS's earnings are expected to grow with 34.84% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.97
PEG (5Y)9.21
EPS Next 2Y34.84%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for ALERS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
EPA:ALERS (8/5/2025, 7:00:00 PM)
25.1
-0.35 (-1.38%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners4.28%
Inst Owner ChangeN/A
Ins Owners0.16%
Ins Owner ChangeN/A
Market Cap257.27M
Analysts84.44
Price Target30.6 (21.91%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 62.75 | ||
| Fwd PE | 21.01 | ||
| P/S | 1.66 | ||
| P/FCF | 19.13 | ||
| P/OCF | 15.4 | ||
| P/B | 1.44 | ||
| P/tB | 10.22 | ||
| EV/EBITDA | 8.75 |
EPS(TTM)0.4
EY1.59%
EPS(NY)1.19
Fwd EY4.76%
FCF(TTM)1.31
FCFY5.23%
OCF(TTM)1.63
OCFY6.49%
SpS15.08
BVpS17.43
TBVpS2.46
PEG (NY)1.97
PEG (5Y)9.21
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.55% | ||
| ROE | 2.24% | ||
| ROCE | 6.39% | ||
| ROIC | 4.25% | ||
| ROICexc | 4.76% | ||
| ROICexgc | 24.83% | ||
| OM | 8.81% | ||
| PM (TTM) | 2.59% | ||
| GM | 46.49% | ||
| FCFM | 8.7% |
ROA(3y)3.54%
ROA(5y)16.42%
ROE(3y)6.48%
ROE(5y)25.15%
ROIC(3y)5.13%
ROIC(5y)17.09%
ROICexc(3y)7.07%
ROICexc(5y)35.47%
ROICexgc(3y)44.03%
ROICexgc(5y)78.19%
ROCE(3y)7.73%
ROCE(5y)25.78%
ROICexcg growth 3Y-35.35%
ROICexcg growth 5Y49.79%
ROICexc growth 3Y-58%
ROICexc growth 5Y39.27%
OM growth 3Y-38.55%
OM growth 5Y55.68%
PM growth 3Y-57.11%
PM growth 5Y-13.49%
GM growth 3Y-5.65%
GM growth 5Y7%
F-Score7
Asset Turnover0.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.17 | ||
| Debt/FCF | 2.53 | ||
| Debt/EBITDA | 1.02 | ||
| Cap/Depr | 19.09% | ||
| Cap/Sales | 2.11% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 54.46% | ||
| Profit Quality | 336.34% | ||
| Current Ratio | 2.03 | ||
| Quick Ratio | 1.42 | ||
| Altman-Z | 3.8 |
F-Score7
WACC6.94%
ROIC/WACC0.61
Cap/Depr(3y)26.09%
Cap/Depr(5y)27.29%
Cap/Sales(3y)2.36%
Cap/Sales(5y)1.86%
Profit Quality(3y)322.49%
Profit Quality(5y)228.98%
High Growth Momentum
Growth
EPS 1Y (TTM)-7.6%
EPS 3Y-58.79%
EPS 5Y6.82%
EPS Q2Q%-100.04%
EPS Next Y31.82%
EPS Next 2Y34.84%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)18.89%
Revenue growth 3Y-5.77%
Revenue growth 5Y21.21%
Sales Q2Q%14.74%
Revenue Next Year9.49%
Revenue Next 2Y9.25%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-6.36%
EBIT growth 3Y-42.09%
EBIT growth 5Y88.7%
EBIT Next Year35.62%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-40.8%
FCF growth 3Y-40.57%
FCF growth 5Y31.67%
OCF growth 1Y-37.6%
OCF growth 3Y-36.72%
OCF growth 5Y27.33%